For the evaluation of connective-tissue disease-associated ILD, markers such as RF, ACPA, anti-Scl-70 and anti-melanoma differentiation-associated gene 5 (MDA5), anti-tRNA synthetase antibodies are considered useful [28]. This evidence concerns the gene IFIH1 and interstitial lung disease.